Skip to Main Navigation Skip to the Content Skip to the Footer
Clinical Trials TJ004309STM103

TJ004309STM103: A Phase 2 Clinical Study of TJ004309 in Combination with Atezolizumab (TECENTRIQ(r)) in Patients with Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors

A Clinical Trial for Ovarian cancer in
  • Covington
.

This is a multicenter, open label, Phase 2 study of TJ004309 in combination with atezolizumab in patients with advanced or metastatic solid tumors.

Learn More